Concepedia

Author

Katharina Pock

Octapharma (Austria)

Also Known As

K. Pock, Katharina Pock, Pock, K

32

Publications

485

Citations

11

H-Index

33

Concepts

All Affiliations

Octapharma (Austria)TU WienUniversity of ViennaShimadzu (United Kingdom)
KP

About

Katharina Pock is an author at Octapharma (Austria) specializing in medicine, clinical chemistry, and bioanalysis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

228

2

Biochemistry

2

2

50

3

Health Sciences

1

1

23

4

Natural Sciences

1

1

27

5

Biomedical Engineering

1

1

23

Katharina Pock

×

13

Publications

380

Citations

10

H-Index

YearCitations

Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS/MS

Gerald Stübiger, Elsie Aldover‐Macasaet, Wolfgang Bicker,

Atherosclerosis

2012

82

Characterization of cysteinylation of pharmaceutical‐grade human serum albumin by electrospray ionization mass spectrometry and low‐energy collision‐induced dissociation tandem mass spectrometry

Martina Kleinova, Omar Belgacem, Katharina Pock,

Rapid Communications in Mass Spectrometry

2005

57

Characterisation of a novel high-purity, double virus inactivated von Willebrand Factor and Factor VIII concentrate (Wilate®)

M. Stadler, Gerhard Grüber, Christoph Kannicht,

Biologicals

2006

43

Identification Of Activated FXI As The Major Biochemical Root Cause In IVIG Batches Associated With Thromboembolic Events. Analytical And Experimental Approaches Resulting In Corrective And Preventive Measures Implemented Into The Octagam® Manufacturing Process

Juergen R Roemisch, Waltraud Kaar, Alfred Zoechling,

2011

30

Molecular mass determination of plasma‐derived glycoproteins by ultraviolet matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry with internal calibration

Omar Belgacem, Andrea Buchacher, Katharina Pock,

Journal of Mass Spectrometry

2002

27

Biochemical characterization, stability, and pathogen safety of a new fibrinogen concentrate (fibryga ® )

Petra Schulz, W. Gehringer, Sabine Nöhring,

Biologicals

2018

27

Selective solid‐phase isolation of methionine‐containing peptides and subsequent matrix‐assisted laser desorption/ionisation mass spectrometric detection of methionine‐ and of methionine‐sulfoxide‐containing peptides

Tom Grunert, Katharina Pock, Andrea Buchacher,

Rapid Communications in Mass Spectrometry

2003

24

Isolation of esterified fatty acids bound to serum albumin purified from human plasma and characterised by MALDI mass spectrometry

Omar Belgacem, Gerald Stübiger, Guenter Allmaier,

Biologicals

2006

23

Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas®) and a development product (Uniplas®)

Katharina Pock, Andrea Heger, S. Janisch,

Transfusion and Apheresis Science

2007

23

Vitronectin in clotting factor IX concentrates

D. Josić, Christoph Kannicht, Klemens Löster,

Haemophilia

2001

14

Page 1